Methyl 3-(2-aminothiazol-4-yl)propanoate hydrochloride | 436099-75-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: Methyl 3-(2-aminothiazol-4-yl)propanoate hydrochloride
• 英文别名: methyl 3-(2-amino-1,3-thiazol-4-yl)propanoate;hydrochloride
• CAS: 436099-75-1
• 化学式: C₇H₁₀N₂O₂S*ClH
• 分子量: 222.696
• InChiKey: ILKHKOJGFKFKPZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.25
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  93.4
• 氢给体数：
  2
• 氢受体数：
  5

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2934100090

反应信息

• 作为反应物：
  描述：

  1-cyclohexylmethyl-2-oxo-1,2,5,6,7,8,9,10-octahydro-cycloocta[b]pyridine-3-carboxylic acid chloride 、 Methyl 3-(2-aminothiazol-4-yl)propanoate hydrochloride 在 三乙胺 作用下， 生成 methyl 3-(2-(1-(cyclohexylmethyl)-2-oxo-1,2,5,6,7,8,9,10-octahydrocycloocta[b]pyridine-3-carboxamido)thiazol-4-yl)propanoate
  参考文献：
  名称：

  Discovery of S-444823, a potent CB1/CB2 dual agonist as an antipruritic agent

  摘要：

  The optimization of a series of 3-carbamoyl 2-pyridone derivatives as CB agonists is reported. These efforts resulted in the discovery of 3-(2-(1-(cyclohexylmethyl)-2-oxo-1,2,5,6,7,8,9,10-octahydrocycloocta[b]pyridine-3-carboxamido)thiazol-4-yl)propanoic acid (21), a potent dual CB1/CB2 agonist without CNS side effects induced by CB1 receptor activation. It exhibited strong inhibition of scratching as a 1.0% acetone solution in the pruritic model. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2012.02.050

文献信息

• [EN] PHOSPHADIAZINE HCV POLYMERASE INHIBITORS IV<br/>[FR] INHIBITEURS IV DE LA PHOSPHADIAZINE POLYMÉRASE VHC
  申请人：IDENIX PHARMACEUTICALS INC

  公开号：WO2009032180A1

  公开（公告）日：2009-03-12

  Provided herein are phosphadiazine polymerase inhibitor, for example, of any of Formulas (IV), (IV), (I'), (II'), or (IVa), pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.

  本文提供了磷二氮杂环聚合酶抑制剂，例如任何公式(IV)，(IV)，(I')，(II')或(IVa)中的化合物，以及包含这些化合物的制药组合物和制备方法。还提供了它们用于治疗宿主中需要治疗HCV感染的方法。
• PHOSPHADIAZINE HCV POLYMERASE INHIBITORS IV
  申请人：IDENIX Pharmaceuticals, Inc.

  公开号：EP2183260A1

  公开（公告）日：2010-05-12
• US7932240B2
  申请人：——

  公开号：US7932240B2

  公开（公告）日：2011-04-26
• Discovery of S-444823, a potent CB1/CB2 dual agonist as an antipruritic agent
  作者：Masahide Odan、Natsuki Ishizuka、Yoshiharu Hiramatsu、Masanao Inagaki、Hiroshi Hashizume、Yasuhiko Fujii、Susumu Mitsumori、Yasuhide Morioka、Masahiko Soga、Masashi Deguchi、Kiyoshi Yasui、Akinori Arimura

  DOI：10.1016/j.bmcl.2012.02.050

  日期：2012.4

  The optimization of a series of 3-carbamoyl 2-pyridone derivatives as CB agonists is reported. These efforts resulted in the discovery of 3-(2-(1-(cyclohexylmethyl)-2-oxo-1,2,5,6,7,8,9,10-octahydrocycloocta[b]pyridine-3-carboxamido)thiazol-4-yl)propanoic acid (21), a potent dual CB1/CB2 agonist without CNS side effects induced by CB1 receptor activation. It exhibited strong inhibition of scratching as a 1.0% acetone solution in the pruritic model. (C) 2012 Elsevier Ltd. All rights reserved.